A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Annexon, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 41,200 shares of ANNX stock, worth $211,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,200
Previous 243,700 83.09%
Holding current value
$211,768
Previous $1.19 Million 79.65%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.49 - $7.2 $25,314 - $40,593
5,638 New
5,638 $33,000
Q1 2024

May 15, 2024

SELL
$4.03 - $7.81 $3.22 Million - $6.24 Million
-799,012 Reduced 75.54%
258,675 $1.85 Million
Q4 2023

Feb 14, 2024

BUY
$1.63 - $4.63 $607,541 - $1.73 Million
372,725 Added 54.42%
1,057,687 $4.8 Million
Q3 2023

Nov 14, 2023

SELL
$2.13 - $3.84 $101,554 - $183,083
-47,678 Reduced 6.51%
684,962 $1.62 Million
Q2 2023

Aug 14, 2023

SELL
$2.1 - $6.37 $3.53 Million - $10.7 Million
-1,680,477 Reduced 69.64%
732,640 $2.58 Million
Q1 2023

May 15, 2023

BUY
$3.74 - $7.46 $2.04 Million - $4.08 Million
546,334 Added 29.27%
2,413,117 $9.29 Million
Q4 2022

Feb 14, 2023

BUY
$4.56 - $6.61 $2.1 Million - $3.05 Million
460,678 Added 32.76%
1,866,783 $9.65 Million
Q3 2022

Nov 14, 2022

SELL
$3.75 - $6.63 $290,842 - $514,209
-77,558 Reduced 5.23%
1,406,105 $8.69 Million
Q2 2022

Aug 15, 2022

SELL
$2.11 - $4.06 $542,917 - $1.04 Million
-257,307 Reduced 14.78%
1,483,663 $5.59 Million
Q1 2022

May 16, 2022

BUY
$2.73 - $11.94 $718,940 - $3.14 Million
263,348 Added 17.82%
1,740,970 $4.75 Million
Q4 2021

Feb 14, 2022

SELL
$11.49 - $22.0 $4.42 Million - $8.47 Million
-385,001 Reduced 20.67%
1,477,622 $17 Million
Q3 2021

Nov 15, 2021

SELL
$16.35 - $23.4 $2.17 Million - $3.11 Million
-132,780 Reduced 6.65%
1,862,623 $34.7 Million
Q2 2021

Aug 16, 2021

SELL
$17.81 - $27.48 $1.75 Million - $2.69 Million
-98,022 Reduced 4.68%
1,995,403 $44.9 Million
Q1 2021

May 17, 2021

SELL
$22.0 - $35.01 $939,180 - $1.49 Million
-42,690 Reduced 2.0%
2,093,425 $58.3 Million
Q4 2020

Feb 16, 2021

BUY
$20.81 - $30.55 $744,893 - $1.09 Million
35,795 Added 1.7%
2,136,115 $53.5 Million
Q3 2020

Nov 16, 2020

BUY
$17.5 - $30.23 $36.8 Million - $63.5 Million
2,100,320 New
2,100,320 $63.5 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $245M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.